Redox active metalloporphyrin
Total Trials
11
As Lead Sponsor
9
As Collaborator
2
Total Enrollment
714
NCT02990468
A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 19, 2017
Completion: Mar 31, 2022
NCT03386500
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
Role: Collaborator
Start: Nov 28, 2017
Completion: Dec 31, 2029
NCT03381625
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Phase: Phase 2
Start: Jan 2, 2018
Completion: Jul 24, 2021
NCT03756389
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
Start: Jan 3, 2018
Completion: Mar 31, 2025
NCT02655601
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Start: Sep 25, 2018
Completion: Dec 31, 2024
NCT03608020
A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy
Start: Oct 4, 2018
Completion: Apr 15, 2024
NCT03752242
Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.
Start: Jan 3, 2019
Completion: Aug 31, 2020
NCT04607642
Trial of BMX-001 or Placebo in Head and Neck Cancer Patients
Start: Jul 31, 2021
Completion: Jul 31, 2025
NCT05254327
Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
Start: Aug 15, 2022
Completion: Jun 30, 2029
NCT05491447
A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
Start: Jan 8, 2023
NCT06620029
BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer
Start: Apr 1, 2025
Completion: Jul 31, 2027
Loading map...